NMDA Receptor
NMDA Receptor(NMDA受体)
NMDA (N-methyl-D-aspartate) receptor is a glutamate-gated cation channels that plays a vital role in regulating synaptic transmission, neuroplasticity and central nervous system development. It is involved in a range of physiological processes such as learning, memory and pain etc.
NMDA Receptor 相关产品(76)
- GC15270(-)-MK-801 maleateCAS: 121917-57-5纯度: >98.00%
(-)-MK 801是一种选择性、非竞争性N-甲基-D-天冬氨酸（NMDA）受体拮抗剂（K i = 211.7nM）。
- GC15363Felbamate hydrateCAS: 1177501-39-1
An inhibitor of NMDA receptors and a modulator of GABA A receptors
- GC16986SDZ 220-581 hydrochlorideCAS: 179411-93-9纯度: >99.50%
SDZ 220-581 hydrochloride 是一种口服有效的竞争性 NMDA 受体拮抗剂，pKi 值为 7.7。
- GC10370(S)-(-)-HA-966CAS: 111821-58-0
(S)-(-)-HA-966 ((-)-HA 966) 是一种 γ-Hydroxybutyrate 样剂，作为 NMDA 受体拮抗剂的活性较弱。
- GC10574Norketamine hydrochlorideCAS: 79499-59-5纯度: >98.00%
Major metabolite of ketamine, NMDA receptor antagonist
- GC10595threo Ifenprodil hemitartrateCAS: 1312991-83-5
σ receptor agonist and NR2B subunit-selective NMDA receptor antagonist
- GC10792Co 101244 hydrochlorideCAS: 193356-17-1
Co 101244 (PD 174494) hydrochloride 是一种含有 NR2B 的 NMDA 受体拮抗剂。
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC10522 | Felbamate | 25451-15-4 | >98.00% | |
An inhibitor of NMDA receptors and a modulator of GABA A receptors | ||||
| GC11470 | Flupirtine maleate | 75507-68-5 | >99.50% | |
An activator of Kv7 channels | ||||
| GC14039 | MDL-29951 | 130798-51-5 | >99.50% | |
An NMDA receptor antagonist and GPR17 agonist | ||||
| GC15270 | (-)-MK-801 maleate | 121917-57-5 | >98.00% | |
(-)-MK 801是一种选择性、非竞争性N-甲基-D-天冬氨酸（NMDA）受体拮抗剂（K i = 211.7nM）。 | ||||
| GC15363 | Felbamate hydrate | 1177501-39-1 | - | |
An inhibitor of NMDA receptors and a modulator of GABA A receptors | ||||
| GC16616 | (+)-MK 801 | 70449-94-4 | >98.00% | |
强效 NMDA 拮抗剂 | ||||
| GC16986 | SDZ 220-581 hydrochloride | 179411-93-9 | >99.50% | |
SDZ 220-581 hydrochloride 是一种口服有效的竞争性 NMDA 受体拮抗剂，pKi 值为 7.7。 | ||||
| GC18118 | SDZ 220-581 | 174575-17-8 | >99.00% | |
SDZ 220-581 是一种具有口服活性、强效、竞争性 NMDA 受体拮抗剂，pKi 值为 7.7。 | ||||
| GC10043 | D-CPP-ene | 117414-74-1 | - | |
NMDA antagonist | ||||
| GC10085 | DQP 1105 | 380560-89-4 | - | |
DQP 1105是一种N-甲基-D-天冬氨酸（NMDA）受体的非竞争性拮抗剂，可抑制含GluN2C和GluN2D亚基受体，IC 50 值分别为7.0μM和2.7μM。 | ||||
| GC10114 | Homoquinolinic acid | 490-75-5 | - | |
NMDA receptor agonist | ||||
| GC10122 | CGP 37849 | 127910-31-0 | >99.00% | |
CGP 37849 是一种有效的、竞争性的和具有口服活性的 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂。 | ||||
| GC10168 | (R)-4-Carboxyphenylglycine | 134052-68-9 | - | |
NMDA receptor antagonist | ||||
| GC10237 | (±)-1-(1,2-Diphenylethyl)piperidine maleate | 207461-99-2 | - | |
NMDA receptor antagonist | ||||
| GC10247 | PPDA | 684283-16-7 | - | |
PPDA 是一种亚型选择性 NMDA 受体拮抗剂，它优先与含有 NR2C/NR2D 的受体结合。 | ||||
| GC10370 | (S)-(-)-HA-966 | 111821-58-0 | - | |
(S)-(-)-HA-966 ((-)-HA 966) 是一种 γ-Hydroxybutyrate 样剂，作为 NMDA 受体拮抗剂的活性较弱。 | ||||
| GC10471 | Ifenprodil hemitartrate | 23210-58-4 | >99.50% | |
An NMDA receptor antagonist | ||||
| GC10476 | (RS)-CPP | 100828-16-8 | - | |
NMDA antagonist | ||||
| GC10574 | Norketamine hydrochloride | 79499-59-5 | >98.00% | |
Major metabolite of ketamine, NMDA receptor antagonist | ||||
| GC10595 | threo Ifenprodil hemitartrate | 1312991-83-5 | - | |
σ receptor agonist and NR2B subunit-selective NMDA receptor antagonist | ||||
| GC10688 | MNI-caged-D-aspartate | 845555-94-4 | - | |
Agonist at NMDA receptors and EAAT substrate | ||||
| GC10696 | L-689,560 | 139051-78-8 | >99.00% | |
L-689,560 是一种有效的 N-甲基-D-天冬氨酸 (NMDA) 受体拮抗剂，作用于 GluN1 甘氨酸结合位点。 | ||||
| GC10792 | Co 101244 hydrochloride | 193356-17-1 | - | |
Co 101244 (PD 174494) hydrochloride 是一种含有 NR2B 的 NMDA 受体拮抗剂。 | ||||
| GC10866 | Spermidine trihydrochloride | 334-50-9 | >99.00% | |
An endogenous polyamine | ||||